LOTTE BIOLOGICS (CEO James Park) and SK pharmteco (CEO Joerg Ahlgrimm) announced that they have signed a Letter of Intent ...

Grit Biotherapeutics Co., Ltd. ("Grit Bio"), a leading clinical-stage biopharmaceutical company pioneering next-generation ...

Without such a framework, the language risks continued fragmentation, inconsistent development, and limited functionality in ...

SK pharmteco and LOTTE BIOLOGICS have announced that they have signed a Letter of Intent (LOI) for a strategic collaboration to strengthen their competitiveness in the global antibody-drug conjugate ...

Simtra BioPharma expands globally, advancing sterile injectable manufacturing and biopharma innovation through strategic partnerships.

Amerigo Scientific is a reliable source for high-quality reagents, kits, and consumables for the life science industry. Most recently, the company released their transglutaminase (TGase) protein ...

Intensity Therapeutics, Inc. ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary cancer therapies using its non-covalent ...

Piramal Pharma Solutions has joined forces with IntoCell to broaden its bioconjugates offering and support innovation in the ...

A recent study found that phototherapy induces chemical changes to bilirubin that may lead to inaccurate and nonsensical measurements.

After Pfizer agreed to acquire weight-loss drug developer Metsera for $7.3 billion, Novo Nordisk swooped in with an ...